Pharmacogenomics Market - 2023-2033

January 2026 | 207 pages | ID: PF351EFA4873EN
DataM Intelligence

Abstracts

The Pharmacogenomics Market was valued at US$ 3.59 Billion in 2023 and is anticipated to reach US$ 8.87 Billion by 2033, at a CAGR of 0.098 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Pharmacogenomics Market.

This report delivers a comprehensive overview of the Pharmacogenomics Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmacogenomics Market. The Pharmacogenomics Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2033.

Pharmacogenomics Market Scope:

Key Players

• Baxter International Inc.

Major Highlights

This report delivers a comprehensive overview of the Pharmacogenomics Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmacogenomics Market. The Pharmacogenomics Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product and Service Type
2.4. Snippet by Technology
2.5. Snippet by Application
2.6. Snippet by Disease Area
2.7. Snippet by Region

3. DYNAMICS

3.1. Impacting Factors
  3.1.1. Drivers
    3.1.1.1. Advancements in Genomic Technologies
    3.1.1.2. Rising Demand for Precision Medicine
    3.1.1.3. Increasing Prevalence of Chronic & Genetic Diseases
  3.1.2. Restraints
    3.1.2.1. High Cost of Research and Testing
    3.1.2.2. Complex Regulatory and Approval Processes
    3.1.2.3. Data Privacy and Ethical Concerns
  3.1.3. Opportunity

4. EXPANSION IN EMERGING MARKETS

4.1. Integration of Artificial Intelligence (AI) and Digital Health
  4.1.1. Development of Multiomic and 3D Genomics Solutions
  4.1.2. Impact Analysis

5. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

5.1. Market Leaders and Pioneers
  5.1.1. Emerging Pioneers and Prominent Players
  5.1.2. Established leaders with the largest-selling Brand
  5.1.3. Market leaders with established Product
5.2. Latest Developments and Breakthroughs
5.3. Regulatory and Reimbursement Landscape
  5.3.1. North America
  5.3.2. Europe
  5.3.3. Asia Pacific
  5.3.4. South America
  5.3.5. Middle East & Africa
5.4. Porter’s Five Forces Analysis
5.5. Supply Chain Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. Unmet Needs and Gaps
5.9. Recommended Strategies for Market Entry and Expansion
5.10. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
5.11. Pricing Analysis and Price Dynamics

6. GLOBAL PHARMACOGENOMICS MARKET, BY PRODUCT AND SERVICE TYPE

6.1. Introduction
  6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product and Service Type
  6.1.2. Market Attractiveness Index By Product and Service Type
6.2. Kits & Reagents*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  6.2.3. Sequencing Kits & Reagents
  6.2.4. PCR Kits & Reagents
  6.2.5. Microarray Kits & Reagents
  6.2.6. Others
6.3. Instruments
6.4. Software & Services

7. GLOBAL PHARMACOGENOMICS MARKET, BY TECHNOLOGY

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  7.1.2. Market Attractiveness Index By Technology
7.2. DNA Sequencing*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Polymerase Chain Reaction (PCR)
7.4. Microarray
7.5. Electrophoresis
7.6. Mass Spectrometry
7.7. Others

8. GLOBAL PHARMACOGENOMICS MARKET, BY APPLICATION

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  8.1.2. Market Attractiveness Index By Application
8.2. Drug Discovery*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Personalized Medicine
8.4. Clinical Research
8.5. Others

9. GLOBAL PHARMACOGENOMICS MARKET, BY DISEASE AREA

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Area
  9.1.2. Market Attractiveness Index, By Disease Area
9.2. Oncology*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Cardiovascular Disorders
9.4. Neurological Diseases
9.5. Infectious Diseases
9.6. Mental Health
9.7. Others

10. GLOBAL PHARMACOGENOMICS MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  10.1.2. Market Attractiveness Index, By Region
10.2. North America
  10.2.1. Introduction
  10.2.2. Key Region-Specific Dynamics
  10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service Type
  10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Area
  10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.2.7.1. U.S.
    10.2.7.2. Canada
    10.2.7.3. Mexico
10.3. Europe
  10.3.1. Introduction
  10.3.2. Key Region-Specific Dynamics
  10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service Type
  10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Area
  10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.3.7.1. Germany
    10.3.7.2. U.K.
    10.3.7.3. France
    10.3.7.4. Spain
    10.3.7.5. Italy
    10.3.7.6. Rest of Europe
10.4. South America
  10.4.1. Introduction
  10.4.2. Key Region-Specific Dynamics
  10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service Type
  10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Area
  10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.4.7.1. Brazil
    10.4.7.2. Argentina
    10.4.7.3. Rest of South America
10.5. Asia-Pacific
  10.5.1. Introduction
  10.5.2. Key Region-Specific Dynamics
  10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service Type
  10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Area
  10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.5.7.1. China
    10.5.7.2. India
    10.5.7.3. Japan
    10.5.7.4. South Korea
    10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
  10.6.1. Introduction
  10.6.2. Key Region-Specific Dynamics
  10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service Type
  10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Area

11. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

11.1. Competitive Overview and Key Market Players
11.2. Market Share Analysis and Positioning Matrix
11.3. Strategic Partnerships, Mergers & Acquisitions
11.4. Key Developments in Product Portfolios and Innovations
11.5. Company Benchmarking

12. COMPANY PROFILES

12.1. Baxter International Inc.*
  12.1.1. Company Overview
  12.1.2. Product Portfolio
    12.1.2.1. Product Description
    12.1.2.2. Product Key Performance Indicators (KPIs)
    12.1.2.3. Historic and Forecasted Product Sales
    12.1.2.4. Product Sales Volume

13. FINANCIAL OVERVIEW

13.1. Company Revenue
  13.1.1. Geographical Revenue Shares
    13.1.1.1. Revenue Forecasts
  13.1.2. Key Developments
    13.1.2.1. Mergers & Acquisitions
    13.1.2.2. Key Product Development Activities
    13.1.2.3. Regulatory Approvals, etc.
  13.1.3. SWOT Analysis

14. ABBOTT LABORATORIES

14.1. Agilent Technologies Inc.
14.2. Becton, Dickinson and Company
14.3. Biomerieux
14.4. Bio-Rad Laboratories Inc.
14.5. illumina
14.6. Eurofins Scientific
14.7. Pacific Biosciences of California Inc.
14.8. Qiagen
14.9. Thermo Fisher Scientific Inc. (LIST NOT EXHAUSTIVE)

15. ASSUMPTIONS AND RESEARCH METHODOLOGY

15.1. Data Collection Methods
15.2. Data Triangulation
15.3. Forecasting Techniques
15.4. Data Verification and Validation

16. APPENDIX

16.1. About Us and Services
16.2. Contact Us